2014 Q1 Form 10-Q Financial Statement

#000119312514199141 Filed on May 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q2 2013 Q1
Revenue $30.24M $25.45M $32.05M
YoY Change -5.64% -4.46% -3.81%
Cost Of Revenue $1.289M $4.280M $1.777M
YoY Change -27.46% -12.83% -9.38%
Gross Profit $28.95M $21.25M $30.27M
YoY Change -4.36% -2.16% -3.47%
Gross Profit Margin 95.74% 83.51% 94.45%
Selling, General & Admin $14.13M $17.47M $17.86M
YoY Change -20.88% 1.45% -1.38%
% of Gross Profit 48.81% 82.21% 59.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $773.0K $4.050M $1.022M
YoY Change -24.36% 297.06% -9.56%
% of Gross Profit 2.67% 19.06% 3.38%
Operating Expenses $17.85M $18.61M $22.19M
YoY Change -19.56% 16.68% -3.77%
Operating Profit -$465.0K $2.640M -$268.0K
YoY Change 73.51% -54.25% -74.57%
Interest Expense $234.0K -$290.0K $300.0K
YoY Change -22.0% -70.41% -71.99%
% of Operating Profit -10.98%
Other Income/Expense, Net -$43.00K $90.00K $93.00K
YoY Change -146.24%
Pretax Income -$681.0K $2.350M -$568.0K
YoY Change 19.89% -50.84% -73.17%
Income Tax -$105.0K $720.0K -$371.0K
% Of Pretax Income 30.64%
Net Earnings -$964.0K $2.163M -$186.0K
YoY Change 418.28% -57.7% -87.95%
Net Earnings / Revenue -3.19% 8.5% -0.58%
Basic Earnings Per Share -$0.10 $0.23 -$0.02
Diluted Earnings Per Share -$0.10 $0.23 -$0.02
COMMON SHARES
Basic Shares Outstanding 9.446M shares 9.443M shares 9.446M shares
Diluted Shares Outstanding 9.443M shares 9.443M shares 9.446M shares

Balance Sheet

Concept 2014 Q1 2013 Q2 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.800M $2.700M $3.200M
YoY Change 18.75% 28.57% 255.56%
Cash & Equivalents $3.823M $2.497M $2.559M
Short-Term Investments
Other Short-Term Assets $8.700M $7.500M $10.10M
YoY Change -13.86% -33.04% -29.37%
Inventory $4.005M $3.798M $3.842M
Prepaid Expenses
Receivables $1.195M $0.00 $13.70M
Other Receivables $300.0K $1.700M $1.100M
Total Short-Term Assets $28.05M $28.09M $31.95M
YoY Change -12.2% -8.25% -12.47%
LONG-TERM ASSETS
Property, Plant & Equipment $29.27M $30.57M $30.48M
YoY Change -3.96% 1.64% -1.37%
Goodwill $461.0K $461.0K $461.0K
YoY Change 0.0% 0.0%
Intangibles $3.067M $3.175M $3.212M
YoY Change -4.51% -4.37%
Long-Term Investments
YoY Change
Other Assets $1.478M $1.587M $1.721M
YoY Change -14.12% 77.52% -85.03%
Total Long-Term Assets $38.58M $39.91M $39.91M
YoY Change -3.35% -17.8% -13.8%
TOTAL ASSETS
Total Short-Term Assets $28.05M $28.09M $31.95M
Total Long-Term Assets $38.58M $39.91M $39.91M
Total Assets $66.63M $68.00M $71.86M
YoY Change -7.28% -14.11% -13.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.174M $5.474M $6.409M
YoY Change -19.27% -21.06% -15.67%
Accrued Expenses $5.900M $5.500M $6.500M
YoY Change -9.23% -23.61% -16.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $9.198M $9.542M $924.0K
YoY Change 895.45% 2.05% -94.56%
Total Short-Term Liabilities $23.94M $22.25M $19.68M
YoY Change 21.61% -30.07% -58.48%
LONG-TERM LIABILITIES
Long-Term Debt $8.453M $8.728M $17.69M
YoY Change -52.21% -36.48% 180.76%
Other Long-Term Liabilities $847.0K $825.0K $796.0K
YoY Change 6.41% -9.04% -82.31%
Total Long-Term Liabilities $10.80M $12.01M $20.70M
YoY Change -47.81% -33.5% 91.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.94M $22.25M $19.68M
Total Long-Term Liabilities $10.80M $12.01M $20.70M
Total Liabilities $34.74M $34.26M $40.38M
YoY Change -13.98% -31.32% -30.85%
SHAREHOLDERS EQUITY
Retained Earnings $14.14M $16.03M $13.87M
YoY Change 1.93% 38.88%
Common Stock $4.722M $4.722M $4.722M
YoY Change 0.0% -0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.89M $33.74M $31.50M
YoY Change
Total Liabilities & Shareholders Equity $66.63M $68.00M $71.86M
YoY Change -7.28% -14.11% -13.21%

Cashflow Statement

Concept 2014 Q1 2013 Q2 2013 Q1
OPERATING ACTIVITIES
Net Income -$964.0K $2.163M -$186.0K
YoY Change 418.28% -57.7% -87.95%
Depreciation, Depletion And Amortization $773.0K $4.050M $1.022M
YoY Change -24.36% 297.06% -9.56%
Cash From Operating Activities -$230.0K $2.330M -$4.470M
YoY Change -94.85% -37.7% -1341.67%
INVESTING ACTIVITIES
Capital Expenditures $336.0K -$2.820M $1.029M
YoY Change -67.35% 213.33% -590.0%
Acquisitions
YoY Change
Other Investing Activities $80.00K $800.0K $110.0K
YoY Change -27.27% -310.53% -1200.0%
Cash From Investing Activities -$360.0K -$2.020M -$910.0K
YoY Change -60.44% 59.06% 313.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -150.0K -370.0K 210.0K
YoY Change -171.43% -71.09% 0.0%
NET CHANGE
Cash From Operating Activities -230.0K 2.330M -4.470M
Cash From Investing Activities -360.0K -2.020M -910.0K
Cash From Financing Activities -150.0K -370.0K 210.0K
Net Change In Cash -740.0K -60.00K -5.170M
YoY Change -85.69% -105.04% -1577.14%
FREE CASH FLOW
Cash From Operating Activities -$230.0K $2.330M -$4.470M
Capital Expenditures $336.0K -$2.820M $1.029M
Free Cash Flow -$566.0K $5.150M -$5.499M
YoY Change -89.71% 10.99% -1064.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
847000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
31888000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7244000
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9443408 shares
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2559000
CY2013Q1 us-gaap Assets Net
AssetsNet
71860000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7239000
CY2013Q4 ssy Amount Of Installment
AmountOfInstallment
150000
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9443000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9443000 shares
CY2014Q1 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2014Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2014Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
24.74 acre
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q1 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
260000
CY2014Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8453000
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36550000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13436000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5174000
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
23935000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3671000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
14136000
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3630000
CY2014Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
17651000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
4722000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66625000
CY2014Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
45000
CY2014Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10802000
CY2014Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2262000
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
9198000
CY2014Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
11305000
CY2014Q1 us-gaap Goodwill
Goodwill
461000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
28049000
CY2014Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9307000
CY2014Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
156000
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3067000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1478000
CY2014Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4301000
CY2014Q1 us-gaap Assets
Assets
66625000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3823000
CY2014Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
18549000
CY2014Q1 us-gaap Escrow Deposit
EscrowDeposit
0
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1195000
CY2014Q1 us-gaap Inventory Net
InventoryNet
4005000
CY2014Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8776000
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65819000
CY2014Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2419000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2965000
CY2014Q1 us-gaap Assets Net
AssetsNet
66625000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4475000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29269000
CY2014Q1 ssy Incentive Reimbursement Assets Current
IncentiveReimbursementAssetsCurrent
125000
CY2014Q1 ssy Due To Third Party Payors
DueToThirdPartyPayors
0
CY2014Q1 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
1502000
CY2011Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
37000
CY2012Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
19000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2057000
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9447000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9447000 shares
CY2013Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2013Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q2 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
216000
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8728000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34266000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13396000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5474000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
22246000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-406000
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
229000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4121000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
825000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
33743000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7761000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16031000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1136000
CY2013Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
18270000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
4722000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68003000
CY2013Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
90000
CY2013Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12014000
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1417000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
9542000
CY2013Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
12356000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
28093000
CY2013Q2 us-gaap Goodwill
Goodwill
461000
CY2013Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9336000
CY2013Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1769000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3175000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1587000
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4113000
CY2013Q2 us-gaap Assets
Assets
68003000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2497000
CY2013Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
20117000
CY2013Q2 us-gaap Escrow Deposit
EscrowDeposit
160000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2013Q2 us-gaap Inventory Net
InventoryNet
3798000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64840000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3505000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4008000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30574000
CY2013Q2 ssy Incentive Reimbursement Assets Current
IncentiveReimbursementAssetsCurrent
0
CY2013Q2 ssy Due To Third Party Payors
DueToThirdPartyPayors
556000
CY2013Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
2461000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9446000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4347000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.34
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9446000 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.59
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.59
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.34
us-gaap Pension Contributions
PensionContributions
43000
us-gaap Revenues
Revenues
91603000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2325000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5239000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2116000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
17176000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
5539000
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
9618000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-3733000
us-gaap Interest Paid
InterestPaid
1485000
us-gaap Net Income Loss
NetIncomeLoss
2325000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
530000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
182000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3214000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
30000
us-gaap Sales Revenue Net
SalesRevenueNet
82780000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2164000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
635000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
796000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
789000
us-gaap Other Expenses
OtherExpenses
-931000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10591000
us-gaap Cost Of Services
CostOfServices
5629000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
18085000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11299000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
386000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
502000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
102000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
290000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1454000
us-gaap Interest Expense
InterestExpense
1506000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
4609000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
51000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15440000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
8823000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2995000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-5931000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
12698000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
108000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
81000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
76000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
39894000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1735000
us-gaap Supplies Expense
SuppliesExpense
6913000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2025000
ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
96000
ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
9832000
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
41000
ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
176000
dei Entity Registrant Name
EntityRegistrantName
SUNLINK HEALTH SYSTEMS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
dei Entity Central Index Key
EntityCentralIndexKey
0000096793
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9443000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Note 2. &#x2013; Business Operations</b></p> <!-- xbrl,body --> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <u>Business Operations</u></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> SunLink Health Systems, Inc., through subsidiaries, owns businesses which are providers of healthcare services in certain markets in the United States. SunLink&#x2019;s business is composed of the ownership of two business segments:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The Healthcare Facilities Segment is composed of three operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Four community hospital subsidiaries in three states with a total of 232 licensed beds;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Two nursing homes with a total of 166 licensed beds, each of which is located adjacent to, or in close proximity with a corresponding SunLink community hospital; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">A healthcare facility which is currently being repurposed for a multi-tenant medical park.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="5%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">The Specialty Pharmacy Segment is composed of four operational areas:</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Retail pharmacy products and services, all of which are conducted in rural markets;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Institutional pharmacy services;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Specialty pharmacy services; and</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt; MARGIN-TOP: 0pt"> &#xA0;</p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="9%">&#xA0;</td> <td valign="top" width="3%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">Durable medical equipment.</td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the specialty pharmacy business since April 2008. The Specialty Pharmacy Segment currently is operated through Carmichael&#x2019;s Cashway Pharmacy, Inc. (&#x201C;Carmichael&#x201D;), a subsidiary of SunLink ScriptsRx, LLC subsidiary, and is composed of a specialty pharmacy business acquired in April 2008 with four service lines.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> SunLink&#x2019;s Board and management have determined to focus the Company&#x2019;s strategic investments on enhancing the existing hospital portfolio, and seeking to improve the operations of its Specialty Pharmacy Segment. The Company believes its four remaining hospital facilities are presently underperforming and currently is evaluating the possible sale of one or more of these hospital facilities. There is no assurance any sale will occur or that, if a sale occurs, it will be at a price that results in a gain or net proceeds after transaction costs, taxes and outstanding debt. The Company expects to use a portion of the net proceeds, if any, from future asset sales to fund its working capital needs.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> On February&#xA0;5, 2013, the Company announced the commencement of a tender offer to purchase at the price of $1.50 per share in cash all of its common shares held by holders of 99 or fewer shares (&#x201C;odd lots&#x201D;) who owned such shares as of the close of business on January&#xA0;31, 2013 (&#x201C;Odd Lot Tender Offer&#x201D;). In addition to the $1.50 per share price, the Company offered each eligible tendering holder a bonus of one hundred dollars ($100) upon completion of the Odd Lot Tender Offer for the tender of all shares&#xA0;beneficially owned by such holder which were received&#xA0;and not withdrawn prior to the date of expiration of the Odd Lot Tender Offer, which was March&#xA0;26, 2013. In accordance with the terms and conditions of the Offer, SunLink accepted for purchase a total of 2,631 common shares of SunLink tendered by 68 holders pursuant to the Offer. As a result of the completion of the Offer, immediately following payment for the tendered shares, the Company has approximately 9,443,000 common shares issued and outstanding and held by approximately 480 stockholders of record. The shares repurchased were retired immediately. The aggregate cash cost of the Odd Lot Tender Offer was $195 and was recorded in equity. Included in the cash cost are purchase price for the odd lot shares of $4, aggregate bonus payments of $7 and fees and expenses of $184.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"> The primary purpose of the Odd Lot Tender Offer was to reduce the number of holders of record of the Company&#x2019;s common shares in order to permit the Company to deregister the common shares with the SEC. The Company&#x2019;s Board and management each believes that deregistering the Company&#x2019;s common shares will result in significant cost savings. Since the Offer failed to accomplish the objective of reducing the number of record holders to fewer than 300, SunLink may in the future take further actions to reduce the number of holders of record of the Company&#x2019;s common shares in order to permit the Company to deregister the common shares with the SEC. As previously disclosed in the Company&#x2019;s offer to purchase, the Board may in the future consider other alternatives to achieve that result, including a further tender offer, a reverse stock split or cash out merger (in which a new corporation is formed to merge with the Company and holders of a limited number of Company shares are cashed out), so long as the Board continues to believe that deregistration remains in the Company&#x2019;s best interests.</p> </div>
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2013-01-01
us-gaap Line Of Credit Facility Initiation Date1
LineOfCreditFacilityInitiationDate1
2008-04-23
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3319000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.02
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.22
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
8308000
us-gaap Pension Contributions
PensionContributions
81000
us-gaap Revenues
Revenues
88498000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1895000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2954000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
18000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-1625000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
620000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
203000
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-2050000
us-gaap Interest Paid
InterestPaid
854000
us-gaap Net Income Loss
NetIncomeLoss
-1895000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
303000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2098000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
21000
us-gaap Sales Revenue Net
SalesRevenueNet
80360000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1213000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
160000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
577000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Other Expenses
OtherExpenses
-1341000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-620000
us-gaap Cost Of Services
CostOfServices
5608000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
8825000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
17838000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11194000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
170000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1326000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
119000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
31000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1381000
us-gaap Interest Expense
InterestExpense
922000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
100000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1373000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
45000
us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
8138000
ssy Number Of Physicians Under Guarantee Agreements
NumberOfPhysiciansUnderGuaranteeAgreements
1 Physician
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
0
ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
456000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2715000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
229000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
108000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
95000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
38292000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
887000
us-gaap Supplies Expense
SuppliesExpense
6553000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-856000
ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
83000
ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
494000
ssy Number Of Law Firms Related To Entities
NumberOfLawFirmsRelatedToEntities
2 Law_Firm
CY2009 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2009
CY2010 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2010
CY2011 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2011
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
218000
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
8000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
18000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9446000 shares
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9446000 shares
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2013Q1 us-gaap Revenues
Revenues
32046000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-186000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-568000
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
11000
CY2013Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
65000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-268000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-186000
CY2013Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-44000
CY2013Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-197000
CY2013Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
10000
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
29240000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1029000
CY2013Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
271000
CY2013Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013Q1 us-gaap Other Expenses
OtherExpenses
93000
CY2013Q1 us-gaap Cost Of Services
CostOfServices
1777000
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7319000
CY2013Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3218000
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
129000
CY2013Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
34000
CY2013Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2013Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
450000
CY2013Q1 us-gaap Interest Expense
InterestExpense
300000
CY2013Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
10000
CY2013Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
17000
CY2013Q1 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
2806000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1022000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38000
CY2013Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
27000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000
CY2013Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13287000
CY2013Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
369000
CY2013Q1 us-gaap Supplies Expense
SuppliesExpense
2213000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-371000
CY2013Q1 ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
45000
CY2013Q1 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
318000
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9443000 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.10
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9443000 shares
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2014Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.10
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2596000
CY2014Q1 us-gaap Revenues
Revenues
30239000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-964000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1283000
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
18000
CY2014Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-53000
CY2014Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-998000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-964000
CY2014Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-88000
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
27718000
CY2014Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-911000
CY2014Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
7000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
362000
CY2014Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
258000
CY2014Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014Q1 us-gaap Other Expenses
OtherExpenses
-43000
CY2014Q1 us-gaap Cost Of Services
CostOfServices
1850000
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2591000
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7078000
CY2014Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3789000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
75000
CY2014Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
40000
CY2014Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
48000
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
462000
CY2014Q1 us-gaap Interest Expense
InterestExpense
303000
CY2014Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-35000
CY2014Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
15000
CY2014Q1 us-gaap Health Care Organization Patient Service Revenue Provisionfor Bad Debts
HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts
2521000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
910000
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36000
CY2014Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
32000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000
CY2014Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12537000
CY2014Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
420000
CY2014Q1 us-gaap Supplies Expense
SuppliesExpense
2058000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-372000
CY2014Q1 ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
16000
CY2014Q1 ssy Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
-15000
CY2013Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
789000

Files In Submission

Name View Source Status
0001193125-14-199141-index-headers.html Edgar Link pending
0001193125-14-199141-index.html Edgar Link pending
0001193125-14-199141.txt Edgar Link pending
0001193125-14-199141-xbrl.zip Edgar Link pending
d700019d10q.htm Edgar Link pending
d700019dex311.htm Edgar Link pending
d700019dex312.htm Edgar Link pending
d700019dex321.htm Edgar Link pending
d700019dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-20140331.xml Edgar Link completed
ssy-20140331.xsd Edgar Link pending
ssy-20140331_cal.xml Edgar Link unprocessable
ssy-20140331_def.xml Edgar Link unprocessable
ssy-20140331_lab.xml Edgar Link unprocessable
ssy-20140331_pre.xml Edgar Link unprocessable